For decades, a number on a scale divided by height squared has served as medicine's shorthand for human health — a blunt instrument in a world of biological complexity. A new study from Keck Medicine of USC, published in the Annals of Internal Medicine, reveals that this shorthand is leaving millions of Americans undiagnosed: a quarter of those with 'normal' BMI and half of those deemed merely 'overweight' carry the abdominal fat and organ stress that define clinical obesity. The findings invite a reckoning with how medicine measures risk, and who gets left out of care when the measuring stick
News-Medical
· Jun 02, 2026
· health
· 3 min read
High
Sourcing: Verified
Study: BMI misses millions with obesity-related health risks
Millions of Americans with undiagnosed obesity-related conditions face increased risk of heart disease, diabetes, and preventable death without proper screening and intervention.
◉
Health & Medicine
8293 related articles
Retatrutide: Eli Lilly's Triple-Action Weight-Loss Drug Poised to Resh…
The Economic Times · 100% match
Rare Kidney Cancer Shows Promise With Immunotherapy, Demands Research …
Oncodaily · 99% match
NIH-developed Sudan virus vaccine shows complete protection in primate…
News-Medical.net · 99% match
GLP-1 drugs linked to lower breast cancer risk, but experts urge cauti…
The Indian Express · 99% match
Global health agencies race to contain Ebola outbreak as vaccine fundi…
Devdiscourse · 99% match
Related Coverage
7NEWS · Aug 23
Model's Foot Cut Led to Heart Surgery, Baby Loss—Now Advocating for Better Diagnostics
Australian model Leah Ramsey lost her baby after a small foot cut triggered a rare heart infection that was repeatedly m…
Informanté · Aug 23 South Africa Shares FMD Vaccines as Region Strengthens Disease ControlsSouth Africa reports its largest-ever FMD outbreak is coming under control through accelerated vaccination and regional …
Al Jazeera · Aug 23 Solar telemedicine kiosks expand healthcare access across rural ChadSolar-powered telemedicine kiosks in rural Chad enable remote doctor consultations at a fraction of traditional travel c…
Inquirer.net · Aug 23 Prince Harry returns to UK amid family rifts, seeking reconciliation with monarchyPrince Harry and Meghan Markle are relocating back to Britain after six years in California, potentially signaling recon…
Bias & Framing
⚖
Article presents USC study findings on BMI limitations with clinical framing favoring newer obesity measurement methods, though maintains generally balanced scientific reporting.
Bias Direction
center-left
Confidence
MED
Problem-solution framing that emphasizes BMI's inadequacy as a diagnostic tool, positioning clinical obesity criteria as a superior alternative. Uses rhetorical questions and expert authority to establish urgency around 'missed' cases.
slip through the cracks
may miss cases
millions of Americans may already have obesity-related health impacts
missing needed health interventions
BMI is problematic
Counterarguments from BMI advocates or researchers defending its utility
Perspectives on potential overdiagnosis risks with clinical obesity criteria
Cost-benefit analysis of expanded treatment eligibility
Patient perspectives on being reclassified as obese
Discussion of implementation challenges for the newer clinical obesity standard
Viewpoints from practitioners who continue using BMI as primary screening tool
Geopolitical Impact
🌎
Medical research finding about BMI limitations has no direct geopolitical implications; this is a domestic healthcare policy matter affecting clinical practice standards.
Escalation Risk
low
Confidence
HIGH
Economic Lens
📈
Study reveals BMI misses 26% of normal-weight and 50% of overweight individuals with clinical obesity, potentially affecting millions' access to treatments and interventions.
Market Signal
bullish
Confidence
HIGH
Healthcare/Medical Services
Pharmaceutical Industry
Medical Device Manufacturing
Health Insurance
Wellness and Fitness Industry
Public Health
Millions of consumers may gain access to previously unavailable obesity treatments and interventions (medications, surgery, lifestyle programs). This could increase out-of-pocket healthcare costs for some but improve health outcomes and reduce long-term disease burden. Consumers with normal/overweight BMI may now qualify for insurance coverage of obesity treatments.
Regulatory bodies (FDA, CMS, insurance companies) may need to revise obesity diagnosis criteria and treatment eligibility guidelines. This could expand insurance coverage for obesity medications and procedures, increasing healthcare spending. Public health agencies may need to update screening protocols and patient education materials. Potential for increased litigation regarding past treatment denials based on BMI-only criteria.